BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer
We wanted to know the reason for the acquisition so we looked at the BioNTech press release about the acquisition and found out the following news.
On June 12, 2025, BioNTech (BNTX
This content is for paid subscribers.
Impacting News
June 30, 2025
